1. Product Name:Docetaxel Injection
2. Product Description:
Docetaxel injection








Description


A light yellow to brown transparent liquid.


?


Indications


This medication is used to treat cancer (such as breast, lung, prostate, stomach, and head/neck cancer). Docetaxel is a member of a family of drugs called taxanes. This drug works by slowing cell growth.


?


Side Effect?


Varies according to indication and treatment regimen


>50%


Alopecia,Anemia,Leukopenia,Neutropenia,A sthenia


10-50%


Fever,Infections,Fluid retention,Hypersensitivity,Skin reactions,Diarrhea,Nausea,Vomiting,Senso ry neuropathy,Myalgia,Nail changes


1-10%


Arthralgia,Thrombocytopenia


?


Contraindications


Hypersensitivity to docetaxel or polysorbate 80


Solid tumor with baseline ANCand protein synthesis inhibition


Pharmacokinetics


Half-life elimination: 11 hr (terminal)


Protein bound: 94-97%


Vd: 80-90 L/m2


Metabolism: Liver (CYP3A4)


Clearance: 21 L/hr/m2


rExcretion: Feces 75%; urine 6%





Related Keywords:


China docetaxel injection manufacturer,China docetaxel injection suppliers,docetaxel injection from China professional pharmaceutical factory,Oncology Drugs , Oncology Nursing Drug , Oncology And Supplementary Drug , Oncology Drugs Manufacturers , Oncology Drugs Suppliers , China Oncology Drugs ,Docetaxel injection




3. Price:10.00
4. Product Website: http://www.sundentpharm.com/oncology/doc etaxel-injection.html
5. Company Description: Sundent Pharm Group
6. Address: ShanghaiShanghaiShanghaiSongjiangNo.1333 Xinlong Road, Shanghai.China.
7. Descption: Sundent Pharm Group (together with its subsidiaries, the Group”) is one of the largest comprehensive manufacturing, marketing, promotion and channel management service provider dedicated to pharmaceutical products.? Since establishment in 2004, the Group has determined to apply global vision to local management, and has introduced a series of pharmaceutical products embedded with technologies that represent international advanced level to China, South America, Eastern European and south Asia countries.? As of Dec 2015, the company had portfolio of pharmaceutical products, covering pain management, cardiovascular, respiratory, gastroenterology, immunology and other therapeutic areas.? At the same time, the Group endeavors to uplift the market value of these brands.

With a global horizon and well-deserved creditability in international market development, the Group has established long-term and stable cooperation with a number of renowned Chinese pharmaceutical manufacturer leaders, independent product quality analysis and develop centers, Chinese SFDA etc., The network lays the foundation of the sustainable development of the company through the comprehensive and effective products introduction and cooperation.

Looking into the future, the Group is committed to build itself into a cutting-edge pharmaceutical manufacturing and marketing group company that grasps the sales channel and product pricing advantage in mainland China. We believe that, with rapid development of China's pharmaceutical industry, through an open-minded attitude, perspective new product introduction capability, accurate product marketing strategy, comprehensive marketing network and effective management system, Sundent Pharmaceutical Group is able to achieve our development target.
8. Registered Capital: 50
9. EmployeeNum: 50
Sundent Pharm Group
10. Contact: Tracy zhang
11. Telphone: 86-21-67897115
12. Fax: 86-21-67897115
13. Email: Sundent@aliyun.com
14. Company Website: http://www.sundentpharm.com